| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2001; 40: 367-374
© 2001 British Society for Rheumatology
Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies
1 Departments of Medicine and
2 Radiology, Flinders Medical Centre,
3 Rheumatology Unit, Flinders Medical Centre, Adelaide, South Australia,
4 Department of Rheumatology, Amsterdam Medical Centre, Amsterdam, The Netherlands,
5 Rheumatology Unit and
6 Department of Pathology, Repatriation General Hospital, Daw Park, Adelaide, South Australia, Australia
Objectives. To document the change in synovial membrane macrophage and T-lymphocyte content in rheumatoid arthritis (RA) patients who achieve remission induced by disease-modifying anti-rheumatic drugs (DMARDs).
Methods. Arthroscopic synovial biopsies were taken from four to seven sites around a knee joint in 13 patients with RA before and at regular intervals after commencing treatment with a DMARD. The cellular content of synovial membrane biopsies taken at regular intervals for a period of up to 3 yr after commencing treatment was quantitated by routine histopathology and immunohistochemical labelling with anti-macrophage (CD68) and anti-T lymphocyte (UCHL-1) antibodies. Synovial biopsies were quantitated with a validated semiquantitative scoring system and video image analysis.
Results. Nine patients obtained clinical remission, as defined by American College of Rheumatology (ACR) criteria. The changes that occurred in the synovial biopsies included a reduction in lining layer thickness, reduced vascularity and cellular infiltrate. The most significant reduction in cellular infiltrate was in the lining layer macrophages, with less dramatic change in the subintimal macrophage infiltrate. Although there was a reduction in CD45 Ro-positive T lymphocytes in the synovial membranes of patients who attained ACR-defined disease remission, it was less significant than the reduction in macrophage content of the synovial membranes and tended to plateau at a reduced level of T-cell infiltration.
Conclusions. Remission in RA patients is characterized by a predominant reduction in macrophage content of the synovial membrane, suggesting that current DMARDs may target this cell and its inflammatory mediators.
KEY WORDS: Rheumatoid arthritis, Synovial membrane, Macrophages, T lymphocytes.
Correspondence to: M. D. Smith, Rheumatology Research Unit, Repatriation General Hospital, Daws Road, Daw Park, South Australia 5041, Australia.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. A. Huynh, T. Hampartzoumian, J. P. Arm, J. Hunt, L. Borges, M. Ahern, M. Smith, C. L. Geczy, H. P. McNeil, and N. Tedla Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugs Rheumatology, May 1, 2007; 46(5): 742 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. O'Gradaigh, S. Bord, D. Ireland, and J. E. Compston Osteoclastic bone resorption in rheumatoid arthritis and the acute-phase response Rheumatology, November 1, 2003; 42(11): 1429 - 1430. [Full Text] [PDF]
|
|
|
|
 |
|
 M Cutolo, A Sulli, P Ghiorzo, C Pizzorni, C Craviotto, and B Villaggio Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis Ann Rheum Dis, April 1, 2003; 62(4): 297 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M D Smith, E Barg, H Weedon, V Papengelis, T Smeets, P P Tak, M Kraan, M Coleman, and M J Ahern Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints Ann Rheum Dis, April 1, 2003; 62(4): 303 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T N Crotti, M D Smith, H Weedon, M J Ahern, D M Findlay, M Kraan, P P Tak, and D R Haynes Receptor activator NF-{kappa}B ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis Ann Rheum Dis, December 1, 2002; 61(12): 1047 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Smith, J. Slavotinek, V. Au, H. Weedon, A. Parker, M. Coleman, P. J. Roberts-Thomson, and M. J. Ahern Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression Rheumatology, September 1, 2001; 40(9): 965 - 977. [Abstract] [Full Text] [PDF]
|
|